What We’ve Discovered About Treating COVID


Sept. 10, 2020 — This previous spring, well being care suppliers at hospitals across the nation scrambled to deal with individuals who had been critically in poor health with a virus they’d solely simply heard of themselves. Normally, when a severely in poor health particular person arrives on the hospital, docs already know or can shortly discover established tips, primarily based on years of analysis, for treating the illness. However within the spring of 2020, nothing was established about COVID-19.

“It was a dramatic scenario. We had lots of sick folks, in a really quick time frame, and it was overwhelming to maintain them. There was an virtually irrational exuberance to attempt any therapy that we might consider,” says David Kaufman, MD, director of medical intensive care at New York College Langone Well being in New York Metropolis.

Whereas docs could have at occasions rushed to attempt something, that trial and error during the last 6 months has helped accumulate the scientific proof of what works and what doesn’t within the therapy of COVID-19.

“The power of the medical group to tug collectively shortly to get these massive important care research achieved in a really quick time frame with dependable, high-quality outcomes is superb,” Kaufman says. “It’s like being in a wartime financial system when all car and fridge factories convert to make tanks and planes.”

The Case for Steroids

At the beginning of the pandemic, docs didn’t have a go-to medicine they might give to critically sick COVID-19 sufferers admitted to their ERs and ICUs. In the present day, corticosteroids are that medicine. Final week, on the heels of a number of scientific research that supported the transfer, the World Well being Group (WHO) released its official suggestion that individuals with extreme COVID-19 obtain steroids to enhance their possibilities of survival.

“Low-dose steroids for 10 days or till the affected person is discharged, whichever one comes first, can really assist with signs, can keep away from escalating to a ventilator, and might decrease the chance of demise,” says Javier Lorenzo, MD, a important care anesthesiologist at Stanford Hospital and Clinics in Stanford, CA.

That’s as a result of steroids act as anti-inflammatories. The worst circumstances of COVID-19 are marked by excessive irritation that doesn’t let up. A bit inflammation firstly of a viral infection helps combat it off. However in severe circumstances of COVID-19, the irritation will get uncontrolled and might finally result in organ failure and demise.

“Steroids will not be good for individuals who have solely had the an infection for a couple of days as a result of they might really restrict the physique’s capability to combat an infection,” Kaufman says. “However in people who find themselves critically in poor health due to over-inflammation, steroids assist put a lid on it.”

Rising Proof for Remdesivir

In Might, the FDA approved hospitals to offer remdesivir to adults and youngsters with extreme COVID-19. In late August, the company expanded that authorization to anybody hospitalized with the virus.

In a study of 1,063 adults within the hospital with COVID-19, those who received remdesivir recovered in about 11 days in comparison with about 15 for many who received a placebo.

“This information is just not fairly as strong as it’s for steroids,” Lorenzo says, “however we all know that sufferers who get remdesivir can expertise sooner decision of signs, shorter length of hospitalization, and be much less more likely to want a ventilator.”

Controversy Over Convalescent Plasma

Additionally in late August, the FDA granted well being care suppliers emergency use authorization for convalescent plasma within the therapy of COVID-19.

Plasma is the a part of the blood that carries antibodies in opposition to viruses. On this case, the therapy makes use of plasma donated by survivors of COVID-19. The concept is that COVID-19 survivors have antibodies that combat the virus. By plasma, docs can go these virus-fighting antibodies onto others struggling to combat the sickness.

The concept dates again to at the least the 1918 Spanish flu pandemic. However it’s unclear simply how useful it’s in COVID-19. There hasn’t been a big, randomized, managed clinical trial to check the results of convalescent plasma to placebo. Some trials are at the moment enrolling volunteers.

“The proof for convalescent plasma is de facto weak,” Lorenzo says. “Not all plasma is equal. Not all plasma has excessive titers [high concentration of antibodies], and never all antibodies neutralize the virus. We’re utilizing it, but it surely’s nonetheless not clear whether or not it’s efficient or not.”

To Intubate or Not

Some important care docs could also be holding off on intubating sufferers and placing them on a mechanical ventilator somewhat longer than they did earlier within the pandemic. Intubation requires heavy sedation and care within the ICU. Early within the pandemic, when docs noticed that sufferers had been progressing of their want for oxygen, many erred on the aspect of warning and put sufferers on a ventilator sooner moderately than later.

On the time, earlier than docs knew the advantages of steroids and remdesivir, the thought was that the affected person would escalate and finally want the ventilator it doesn’t matter what.

“So if we did it early, moderately than ready till it was an emergency, once we might take our time donning the private protecting gear, we might additionally scale back the chance of publicity to our well being care staff,” Lorenzo says.

Medical doctors had been additionally involved that oxygen delivered by means of a tube within the nostril – a step under a mechanical ventilator — might push the virus out into the air and improve publicity threat for well being care staff, too.

“However we now know that in some sufferers, if we give the steroids and remdesivir somewhat bit extra time, and permit them to escalate somewhat additional together with high-flow nasal [oxygen], we’d simply squeak by and never need to put them on a ventilator,” Lorenzo says.

In Stanford’s ICU, Lorenzo says, they’re now assured their workers are protected. “The danger of aerosolization of the virus is actual. However we now know that our well being care supplier an infection charge is low. So if we preserve our full PPE tips, then the chance of transmission is low, and we’d have the ability to stop the affected person from escalating to a ventilator.”

New analysis reveals this can be a protected threat to take. A current study discovered that there was no distinction in survival charges amongst COVID-19 sufferers who went straight on a ventilator and those that had been placed on nasal oxygen first.

Liable to Get better Quicker

Some sufferers on ventilators could get better sooner by spending a while every day mendacity susceptible, or face down. It doesn’t work for everybody. However for many who profit, the thought is that the face-down place could distribute oxygen extra evenly all through the lungs. Lengthy earlier than COVID-19, important care suppliers flipped sedated sufferers on ventilators onto their stomachs to be able to get extra oxygen into their lungs.

However for the reason that pandemic, some ICUs are trying it on sufferers who’re awake and maybe on the way in which to needing a ventilator. Quite a few clinical trials in progress are inspecting the advantages for sufferers who should not but on a ventilator however struggling to get oxygen.

“For some sufferers, the oxygen degree goes up, but it surely’s not common,” Kaufman says. “And shortly after you cease mendacity in your abdomen, the oxygen goes again down.”

Unprecedented Collaboration

On the highway to discovering what works, well being care suppliers have thrown out many issues that proved to not work, too.

“Lots of people had been speaking about hydroxychloroquine,” Lorenzo says. “However we now know, unequivocally, that we shouldn’t be utilizing it. It doesn’t work. And it in all probability may cause extra hurt than good.”

They’ve discovered what works and what doesn’t extra shortly by means of unprecedented collaboration with their co-workers and frontline well being care staff across the globe.

Beneath “regular” circumstances, researchers tightly guard information till it’s revealed. “Now, a few of these trials could launch unpublished information in the event that they really feel that the profit is actual and substantial,” Lorenzo says.

Social media teams for important care docs, he says, are additionally extra energetic than ever.

Kaufman is a part of an electronic mail chain with pulmonologists and important care docs from all around the world. Many are in Europe and received intensive expertise with COVID-19 months forward of docs within the U.S. “To be linked with a number of the worldwide masters in mechanical air flow who’re at a number of the hardest hit cities on the earth is a tremendous privilege. It’s like sitting on the foot of Sophocles, studying from the traditional masters,” he says.

However for all they’ve discovered, a lot continues to be unknown. Medical doctors nonetheless don’t perceive why some sufferers get by means of the virus after per week of gentle signs whereas others escalate to a ventilator in the identical period of time. “We nonetheless don’t understand how sufferers progress on this illness,” Lorenzo says.

However after a frenzied springtime by which many well being care suppliers tried something which may work, Lorenzo says, “We’ve got discovered from this pandemic that we will’t loosen up our scientific rigor. We’ve got to abide by the identical technique of peer-reviewed scientific trials that we usually do or we will hurt sufferers.”


David Kaufman, MD, director, Medical Intensive Care, New York College Langone Well being, New York.

Javier Lorenzo, MD, Stanford Hospital and Clinics, Stanford, CA.

WHO: “Corticosteroids for COVID-19.”

Information launch, FDA.

New England Journal of Drugs: “Remdesivir for the Remedy of Covid-19 — Preliminary Report.”

Annals of Inside Drugs: “Meta-Evaluation: Convalescent Blood Merchandise for Spanish Influenza Pneumonia: A Future H5N1 Remedy?”

Information launch, College of Michigan Well being.

Important Care Drugs: “Timing of Intubation and Mortality Amongst Critically Ailing Coronavirus Illness 2019 Sufferers.”

Information launch, Columbia College.

© 2020 WebMD, LLC. All rights reserved.


Please enter your comment!
Please enter your name here